First Republic Investment Management, Inc. Axonics, Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$47.99 - $60.21 $194,167 - $243,609	-4,046 Reduced 46.04%	4,742 $239,000
Q1 2023 May 11, 2023	BUY	$52.6 - $67.34 $70,694 - $90,504	1,344 Added 18.05%	8,788 $479,000
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $24,181 - $31,099	406 Added 5.77%	7,444 $465,000
Q3 2022 Nov 03, 2022	BUY	$57.96 - $78.12 $407,922 - $549,808	7,038 New	7,038 $496,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

Vanguard Group Inc Valley Forge, PA

5.06M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.34M
Shares

$308 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

2.18M
Shares

$155 Million
6.99% of portfolio
Fil LTD Hamilton, D0

2.04M
Shares

$145 Million
0.14% of portfolio
Westchester Capital Management, LLC Valhalla, NY

1.45M
Shares

$103 Million
4.89% of portfolio

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account